Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gametogenetin-binding protein 2 (GGNBP2) is a zinc finger protein mainly implicated in the regulation of chromatin structure and histone modifications, particularly in the context of spermatogenesis[1][2][3]. It functions as a scaffold protein, interacting with partners such as ASXL1 and UBE2B, and plays a critical role in histone H2A and H2B ubiquitination and H3 methylation, impacting nucleosome stability and DNA repair[1]. GGNBP2 acts as a tumor suppressor in certain cancers and has essential functions in testis morphogenesis, sperm development, and pregnancy maintenance[2]. Alterations or knockout of GGNBP2 lead to male infertility (azoospermia), abnormal spermatogenesis, and, in some contexts, contribute to tumor biology and developmental defects[1][2][3]. GGNBP2 is associated with chromosome 17q12 deletion syndrome and may regulate negative cell proliferation and differentiation processes[2][3]. Currently, there are no known therapeutic drugs targeting GGNBP2 directly, and it is not established as a classic druggable therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gametogenetin-binding protein 2 (GGNBP2).